𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Trauma and posttraumatic stress disorder in treatment-resistant obsessive-compulsive disorder

✍ Scribed by Beth S. Gershuny; Lee Baer; Holly Parker; Emily L. Gentes; Alison L. Infield; Michael A. Jenike


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
96 KB
Volume
25
Category
Article
ISSN
1091-4269

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Depression in comorbid obsessive-compuls
✍ Anna Merrill; Beth Gershuny; Lee Baer; Michael A. Jenike πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 82 KB

Previous findings suggested a unique role that depression symptoms might play in the comorbid relationship between obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD). However, the nature of this role remains unclear. Thus, the current study examined ways in which OCD and PT

Childhood trauma in obsessive-compulsive
✍ Christine Lochner; Pieter L. du Toit; Nompumelelo Zungu-Dirwayi; Adele Marais; J πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 53 KB

There is relatively little data on the link between childhood trauma and obsessive-compulsive/putative obsessive-compulsive spectrum disorders. The revised Childhood Trauma Questionnaire (CTQ), which assesses physical, emotional, and sexual abuse as well as physical and emotional neglect, was admini

Amisulpiride augmentation in treatment r
✍ Γ–zmen Metin; Kemal Yazici; Senel Tot; Aylin Ertekin Yazici πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 60 KB πŸ‘ 1 views

## Abstract Despite the effectiveness of clomipramine and selective serotonin reuptake inhibitors (SSRIs) in the treatment of obsessive–compulsive disorder (OCD), 40% to 60% of patients who receive an adequate treatment with these agents have significant persisting symptoms. Newer atypical antipsyc

SSRIs in the Treatment of obsessive-comp
✍ Charles Cartwright; Eric Hollander πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 58 KB πŸ‘ 2 views

The introduction of the SSRIs (selective serotonin reuptake inhibitors) over the past decade has provided exciting new opportunities for the treatment of obsessive-compulsive disorder (OCD). The serotonin hypothesis, based on the preferential response of OCD to the serotonin reuptake inhibitor, clom